Neil X Krueger is a prominent inventor based in Roslindale, MA (US). He has made significant contributions to the field of bacterial detection, holding a total of 4 patents. His work focuses on developing innovative methods for identifying bacterial and fungal pathogens, which are crucial for clinical diagnostics.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Rapid peptidoglycan-based assay for detection of bacterial contamination." This invention relates to a colorimetric method for detecting bacterial or fungal pathogens by identifying peptidoglycan or (1-3)-β-D-glucan in a sample. Another notable patent involves methods of using novel antigen peptides for detecting specific species in a sample. These methods can be adapted for high blood volume screening and are applicable for the clinical diagnosis of patients with babesiosis or for assaying blood contaminated with specific pathogens.

Career Highlights

Neil X Krueger is currently associated with Immunetics, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the accuracy and efficiency of bacterial detection methods, which are vital for patient care and safety.

Collaborations

Neil has collaborated with notable colleagues, including Andrew E Levin and Andrew Han, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Neil X Krueger's contributions to the field of bacterial detection exemplify the impact of innovative thinking in healthcare. His patents and ongoing work at Immunetics, Inc. highlight the importance of developing effective diagnostic tools for better patient outcomes.